Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-34,121
Closed -$2.9M 279
2021
Q2
$2.9M Sell
34,121
-15,181
-31% -$1.38M 0.45% 56
2021
Q1
$3.9M Buy
49,302
+23,707
+93% +$1.54M 0.59% 21
2020
Q4
$1.49M Buy
+25,595
New +$1.21M 0.24% 192
2019
Q2
Sell
-13,457
Closed -$565K 248
2019
Q1
$565K Sell
13,457
-1,348
-9% -$48.5K 0.14% 238
2018
Q4
$460K Sell
14,805
-281
-2% -$10.4K 0.12% 242
2018
Q3
$656K Buy
+15,086
New +$427K 0.1% 282

Other funds holding AFMD

EAM Investors's AFMD Position: Q3 2021 in Review

EAM Investors sold out of Affimed (AFMD) in Q3 2021, closing a stake of 34,121 shares — an estimated $2.9M sold.

EAM Investors first reported a position in AFMD in Q3 2018 and held it in 6 quarters. The position peaked at $3.9M in Q1 2021. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

  • EAM Investors reported no remaining Affimed position as of Q3 2021 after selling out during the quarter.
  • EAM Investors sold 34,121 Affimed shares in Q3 2021, an estimated $2.9M.
  • EAM Investors first reported a position in Affimed in Q3 2018 and held it in 6 quarters.
  • EAM Investors's Affimed position peaked at $3.9M in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.